Skip to Main Content

Paper Details

DNA methylation identifies genetically and prognostically distinct subtypes of myelodysplastic syndromes.
Blood Adv
28
2019
140749, ASXL1, Bisulfite, DNAm, EZH2, MDS, Patients, RUNX1, SF3B1, SRSF2, TP53, TP53 mutations, U2AF1, bivalent promoters, bone marrow, bone marrow DNA, consensus clusters, cytosine guanine dinucleotides, differentially methylated regulatory loci, enhancers, genetic abnormalities, genetic lesions, methylation, myelodysplastic syndromes, nonoverlapping regulatory regions, patients
Author NameAffiliation
Dinh Diep
Huwate YeernaMoores Cancer Center.
Pablo TamayoMoores Cancer Center.
Pablo TamayoUniversity of California San Diego
Pablo TamayoMoores Cancer Center.
Pablo TamayoUniversity of California San Diego
Kun Zhang
Kun Zhang
Rafael Bejar
Rafael BejarMoores Cancer Center.
  • 1 - 10

Datasets

Release 1.2